Crown Oak Advisors LLC Raises Position in Mettler-Toledo International Inc. (NYSE:MTD)

Crown Oak Advisors LLC increased its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 14.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,644 shares of the medical instruments supplier’s stock after purchasing an additional 702 shares during the period. Mettler-Toledo International accounts for 3.6% of Crown Oak Advisors LLC’s investment portfolio, making the stock its 15th biggest position. Crown Oak Advisors LLC’s holdings in Mettler-Toledo International were worth $6,906,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Apeiron RIA LLC increased its position in Mettler-Toledo International by 22.0% during the fourth quarter. Apeiron RIA LLC now owns 311 shares of the medical instruments supplier’s stock worth $381,000 after purchasing an additional 56 shares during the last quarter. Inspire Investing LLC increased its holdings in shares of Mettler-Toledo International by 0.7% during the 4th quarter. Inspire Investing LLC now owns 2,058 shares of the medical instruments supplier’s stock worth $2,518,000 after buying an additional 14 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Mettler-Toledo International by 458.2% in the 4th quarter. SG Americas Securities LLC now owns 6,911 shares of the medical instruments supplier’s stock worth $8,457,000 after buying an additional 5,673 shares during the period. Eads & Heald Wealth Management raised its position in shares of Mettler-Toledo International by 14.3% in the 4th quarter. Eads & Heald Wealth Management now owns 400 shares of the medical instruments supplier’s stock worth $489,000 after buying an additional 50 shares during the period. Finally, Simon Quick Advisors LLC purchased a new stake in Mettler-Toledo International during the fourth quarter valued at about $206,000. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on MTD. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and raised their price target for the company from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Wells Fargo & Company decreased their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. Finally, Robert W. Baird decreased their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $1,351.25.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,335.76 on Friday. Mettler-Toledo International Inc. has a 12-month low of $1,133.46 and a 12-month high of $1,546.93. The company has a market capitalization of $28.18 billion, a price-to-earnings ratio of 36.01, a price-to-earnings-growth ratio of 4.19 and a beta of 1.12. The firm’s fifty day moving average price is $1,245.04 and its 200 day moving average price is $1,343.30.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. The business had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. Analysts forecast that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In related news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares of the company’s stock, valued at $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Gerry Keller sold 140 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.